Literature DB >> 17557426

The scoring of respiratory events in sleep: reliability and validity.

Susan Redline1, Rohit Budhiraja, Vishesh Kapur, Carole L Marcus, Jason H Mateika, Reena Mehra, Sariam Parthasarthy, Virend K Somers, Kingman P Strohl, Loreto G Sulit, David Gozal, Merrill S Wise, Stuart F Quan.   

Abstract

The American Academy of Sleep Medicine Task Force on Respiratory Scoring reviewed the evidence that addresses: the validity of specific sensors in detecting airflow, tidal volume, oxyhemoglobin saturation, and CO2; the reliability of specific scoring approaches for quantifying sleep related breathing disorders (SRBD); and the validity of using various definitions of the apnea hypopnea index (AHI) as assessed by the strength and consistency of associations with several comorbidities (hypertension, cardiovascular disease, sleepiness, impaired quality of life, and accidents). The evidence was based on a literature search of relevant articles published through December 2004, which resulted in identifying and extracting data from 182 articles, which were graded using standardized approaches. Diverse physiological sensors have been utilized to quantify airflow limitation in patients with suspected SRBD. Although thermistry appears appropriate for identifying apneas, the available evidence did not indicate it provides valid quantification of airflow reduction. The emerging evidence evaluating the accuracy of signal detection against the gold standard measurements (e.g., pneumotachography) suggested the superiority of inductance plethysmography and nasal pressure transducers for detection of hypopneas, with some evidence that recordings from a nasal pressure transducer may better approximate flow/volume than uncalibrated inductance plethysmography. However, since the nasal pressure transducer has only recently been incorporated into large-scale studies, there are as of yet few data that address the predictive value of transducer-identified events relative to clinical or physiological outcomes. Very few studies directly compared the validity of alternative approaches for defining the duration, amplitude change, and use of corroborative data from desaturation or arousal for defining hypopneas. Many observational studies utilizing various designs and approaches for event detection have shown significant associations between measures of SRBD and health outcomes. Data from the 2 largest sleep cohort studies, the Sleep Heart Health Study and the Wisconsin Sleep Cohort, both used definitions of hypopneas based on "discernible" reductions of inductance plethysmography signals with associated desaturation and showed that the derived AHIs using these hypopnea definitions correlated with various indices of morbidity. However, it is not clear whether alternative definitions would provide comparable if not better prediction, or whether optimal approaches for event identification would vary for different outcomes. Despite these limitations, forming a consensus on optimal approaches for recording and measuring respiratory events is an important step toward generating data from different clinical or research laboratories that can be compared. However, additional research is needed, including direct comparisons of alternative measuring approaches for predicting clinical outcomes, with a need to address these issues in large samples across the age spectrum and with inclusion of promising new technology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557426

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  114 in total

1.  Varying Hypopnea Definitions Affect Obstructive Sleep Apnea Severity Classification and Association With Cardiovascular Disease.

Authors:  Christine H J Won; Li Qin; Bernardo Selim; Henry K Yaggi
Journal:  J Clin Sleep Med       Date:  2018-12-15       Impact factor: 4.062

2.  The use of epochs to stage sleep results in incorrect computer-generated AHI values.

Authors:  Mark B Norman; Sally Middleton; Colin E Sullivan
Journal:  Sleep Breath       Date:  2010-04-13       Impact factor: 2.816

3.  Obstructive sleep apnea and age: a double insult to brain function?

Authors:  Liat Ayalon; Sonia Ancoli-Israel; Sean P A Drummond
Journal:  Am J Respir Crit Care Med       Date:  2010-04-15       Impact factor: 21.405

4.  Development of the National Healthy Sleep Awareness Project Sleep Health Surveillance Questions.

Authors:  Timothy I Morgenthaler; Janet B Croft; Leslie C Dort; Lauren D Loeding; Janet M Mullington; Sherene M Thomas
Journal:  J Clin Sleep Med       Date:  2015-09-15       Impact factor: 4.062

5.  Revise Respiratory Event Criteria or Revise Severity Thresholds for Sleep Apnea Definition?

Authors:  Thomas Penzel; Christoph Schöbel; Ingo Fietze
Journal:  J Clin Sleep Med       Date:  2015-12-15       Impact factor: 4.062

6.  A Novel Application of a Biopsychosocial Theory in the Understanding of Disturbed Sleep before and after Kidney Transplantation.

Authors:  Jacob M Williams; Christina S McCrae; James R Rodrigue; Pamela R Patton
Journal:  J Clin Sleep Med       Date:  2016-02       Impact factor: 4.062

7.  The effect of respiratory scoring on the diagnosis and classification of sleep disordered breathing in chronic heart failure.

Authors:  Neil R Ward; Vitor Roldao; Martin R Cowie; Stuart D Rosen; Theresa A McDonagh; Anita K Simonds; Mary J Morrell
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

Review 8.  Diagnostic approaches to respiratory sleep disorders.

Authors:  Renata L Riha
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

9.  The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index.

Authors:  Warren R Ruehland; Peter D Rochford; Fergal J O'Donoghue; Robert J Pierce; Parmjit Singh; Andrew T Thornton
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

10.  Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1.

Authors:  Scott R Plotkin; Stephanie D Davis; Kent A Robertson; Srivandana Akshintala; Julian Allen; Michael J Fisher; Jaishri O Blakeley; Brigitte C Widemann; Rosalie E Ferner; Carole L Marcus
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.